Parallax Volatility Advisers, L.P. Abbott Laboratories Call Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $50 Million - $59 Million	499,700 Added 611.63%	581,400 $66.3 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $20.6 Million - $23.1 Million	-205,000 Reduced 71.5%	81,700 $8.49 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $22.5 Million - $24.8 Million	-205,000 Reduced 41.69%	286,700 $32.6 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $32.6 Million - $39.9 Million	361,600 Added 277.94%	491,700 $54.1 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.78 Million - $2.13 Million	-18,600 Reduced 12.51%	130,100 $12.6 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $13.4 Million - $14.9 Million	-132,600 Reduced 47.14%	148,700 $16.2 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $47.2 Million - $55.5 Million	-487,200 Reduced 63.4%	281,300 $28.5 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $17.4 Million - $20.4 Million	182,600 Added 31.17%	768,500 $84.4 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $38.2 Million - $44.2 Million	394,400 Added 205.95%	585,900 $56.7 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $12.7 Million - $15.3 Million	124,100 Added 184.12%	191,500 $20.8 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $32.5 Million - $39.6 Million	-284,600 Reduced 80.85%	67,400 $7.98 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $36.3 Million - $44.4 Million	314,000 Added 826.32%	352,000 $49.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $6.93 Million - $7.67 Million	-59,400 Reduced 60.99%	38,000 $4.49 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $24.6 Million - $29 Million	-232,500 Reduced 70.48%	97,400 $11.3 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $22.3 Million - $26.3 Million	204,900 Added 163.92%	329,900 $39.5 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $53.8 Million - $58.6 Million	-512,200 Reduced 80.38%	125,000 $13.7 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $38.7 Million - $47 Million	422,300 Added 196.51%	637,200 $69.4 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $61,255 - $78,400	-800 Reduced 0.37%	214,900 $19.6 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $1.66 Million - $2.43 Million	-26,500 Reduced 10.94%	215,700 $17 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $259,083 - $288,420	3,300 Added 1.38%	242,200 $21 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $14.6 Million - $15.8 Million	-178,500 Reduced 42.76%	238,900 $20 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $10 Million - $11.7 Million	137,400 Added 49.07%	417,400 $35.1 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $34.6 Million - $41.8 Million	-521,900 Reduced 65.08%	280,000 $22.4 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $34.5 Million - $39.1 Million	526,100 Added 190.75%	801,900 $58 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $4.61 Million - $5.56 Million	75,800 Added 37.9%	275,800 $20.2 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $9.52 Million - $10.5 Million	165,300 Added 476.37%	200,000 $12.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $1.67 Million - $1.86 Million	34,700	34,700 $1.85 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.9 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.69 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.45 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.04 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account